Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Combining PET amyloid-β (Aβ) and tau imaging may be critical for tracking disease progression in Alzheimer’s disease (AD).

More information Original publication

DOI

10.3233/JAD-170129

Type

Journal article

Journal

Journal of Alzheimer's Disease

Publication Date

29/08/2017

Volume

60

Pages

283 - 293

Keywords

Alzheimer’s disease, amyloid beta-peptides, cerebrospinal fluid proteins, positron emission tomography, tau proteins